Genera Istrazivanja D.O.O.
Records under this name other than the patents Genera Istrazivanja D.O.O. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 4 patents it holds.
Showing 1 to 6 of 6 · Back to Genera Istrazivanja D.O.O.
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 7,850,964 | BMP-1 procollagen c-proteinase for diagnosis and treatment of bone and soft tissue defects and disorders Formerly held In force (reinstated) · From the USPTO record | In force (reinstated) | From the USPTO record | |
| US 8,182,998 | Blood biomarkers for bone fracture and cartilage injury Lapsed on the fee record Ended May 22, 2020 · From the USPTO record | Lapsed on the fee record | Ended May 22, 2020 | From the USPTO record |
| US 8,119,591 | Methods and compositions for regenerating articular cartilage Lapsed on the fee record Ended Feb 21, 2020 · From the USPTO record | Lapsed on the fee record | Ended Feb 21, 2020 | From the USPTO record |
| US 8,796,208 | Methods and compositions for regenerating articular cartilage Lapsed on the fee record Ended Aug 5, 2018 · From the USPTO record | Lapsed on the fee record | Ended Aug 5, 2018 | From the USPTO record |
| US 8,765,127 | Methods of preventing ischemia/reperfusion damage to kidney using antibodies that bind BMP-1 isoforms Lapsed on the fee record Ended Jul 1, 2018 · From the USPTO record | Lapsed on the fee record | Ended Jul 1, 2018 | From the USPTO record |
| US 8,263,072 | ADAMTS4 as a blood biomarker and therapeutic target for chronic renal failure Lapsed on the fee record Ended Sep 11, 2016 · From the USPTO record | Lapsed on the fee record | Ended Sep 11, 2016 | From the USPTO record |